You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitor Naïve

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial (INCB099280)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 19, 2023

Melanoma, Uveal Trial in Portland (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma, Uveal
  • Portland, Oregon
    Providence Portland Medical Center
Aug 2, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Burgas, Bulgaria
  • +19 more
Oct 20, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Malignant Ascites
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Feb 16, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Immune Checkpoint Inhibitor-related Cardiotoxicity

Not yet recruiting
  • Immune Checkpoint Inhibitors, Cardiotoxicity
  • Cardiac magnetic resonance
  • (no location specified)
Nov 10, 2023

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023

EXploring Immune-related Adverse Events of Immune checkpoinT

Active, not recruiting
  • Cancer
  • +2 more
  • Immune checkpoint inhibitor
  • Paris, France
  • +1 more
Jul 5, 2023

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

Not yet recruiting
  • NSCLC Associated With Leptomeningeal Metastases
  • Tislelizumab, pemetrexed
  • (no location specified)
Nov 21, 2023

Immune Checkpoint Inhibitor Monotherapy or Combined With

Not yet recruiting
  • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023

Determine Pro-Inflammatory Cytokine Kinetics During Immune

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Melanoma
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jan 30, 2023

    Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

    Recruiting
    • Lung Squamous Cell Carcinoma
    • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
    • Yancheng, Jiangsu, China
      Yancheng Clinical College of Xuzhou Medical University
    Mar 21, 2023

    Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • +11 more
    • Tucson, Arizona
    • +11 more
    Dec 2, 2022

    Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

    Completed
    • Immune Checkpoint Inhibitor
    • Endocrine Toxicity
      • Nanjing, Jiangsu, China
        First Affiliated Hospital, Nanjing Medical University
      Jan 6, 2023

      Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

      Recruiting
      • Advanced Biliary Tract Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 22, 2023

      Stage IV NSCLC Trial in Houston (Poly ICLC, IVIG)

      Not yet recruiting
      • Stage IV NSCLC
      • Houston, Texas
        Michael E. DeBakey VA Medical Center, Houston, TX
      Sep 28, 2023

      Troponin to Detect Major Cardiovasculaire Advserse Events on

      Recruiting
      • Cancer
      • +2 more
      • No intervention
      • Paris, France
        Institut Mutualiste Montsouris
      Aug 22, 2023

      Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • +3 more
      • Intensity Modulated Radiation Therapy
      • +3 more
      • (no location specified)
      Jul 11, 2023

      Development ofEORTC Immune Checkpoint Inhibitor-specific Quality

      Recruiting
      • Cancer
      • +2 more
        • Paris, France
          Institut Curie
        Nov 2, 2022

        Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • Anlotinib and TQB2450
        • Shanghai, Shanghai, China
          Zhongshan hospital
        Sep 4, 2023

        Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

        Active, not recruiting
        • Melanoma
        • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
        • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
        • Toulouse, France
          Institut Claudius Regaud IUCT-ONCOPOLE
        Nov 18, 2022

        Pre-transplant ICI Exposure and Post-transplant Graft Rejection

        Recruiting
        • Graft Rejection
        • +3 more
        • Immune checkpoint inhibitor
        • Guangzhou, Guangdong, China
          Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
        Jun 21, 2023

        Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

        Not yet recruiting
        • Colitis
        • Aalborg, Denmark
        • +2 more
        Jul 7, 2023